Global point of care
ACT Testing: When There's No Room For Doubt



SUMMARY
ACT tests with some traditional analyzers can lead to highly variable results, raising doubt about the accuracy of critical results1. Additionally, some second-generation systems have diverged from using the traditional standard Celite and Kaolin activator biochemistry.
In this educational webinar, Dr. Falter will introduce different ACT technologies and discuss best use of modern ACT testing technology. He will also discuss the clinical impact that different ACT analysis methods can have, along with key laboratory aspects of coagulation testing during cardiac surgery.
LEARNING OBJECTIVES
- Examine laboratory requirements of test accuracy and reliability
- Differentiate between laboratory and point-of-care approach to intra-operative coagulation testing during cardiac surgery
- Identify the various methods of assessing heparin activity
- Assess the technological differences between different methods of measuring the Activated Clotting Time (ACT)
- Evaluate the clinical impact of the different ACT technologies
This event is produced by Whitehat Communications and sponsored by Abbott.
Titles of those appearing in the recording represent their roles at the time the webinar took place and may not reflect their current positions.
REFERENCES
- Ojito JW et al. J Extra Corpor Technol 2012;44:15-20